Continuous Glucose Monitoring System: Accuracy and Prognostic Value in Critically Ill Patients
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Continuous Glucose Monitoring (CGM) System.
- Who it may be relevant to
- Registry conditions: Critically Ill Patients. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Whether diabetic or non-diabetic patients, blood glucose management during ICU hospitalization is essential. This study aims to evaluate the accuracy of the iCan Continuous Glucose Monitoring (CGM) System for detecting blood glucose levels in ICU patients, as well as its value in prognostic evaluation, to provide reference for blood glucose management in critically ill patients.
Interventions
- Device Continuous Glucose Monitoring (CGM) System
Continuous Glucose Monitoring (CGM) System
Primary outcome measures
- Accuracy [Time frame: Up to eight days]
Eligibility criteria
Inclusion criteria
- Age ≥ 18 years; gender not limited.
- Expected ICU (Intensive Care Unit) stay ≥ 48 hours.
- Patients requiring frequent blood gas monitoring in the ICU.
Exclusion criteria
- The patient or their family refuses to use CGM for blood glucose monitoring.
- Patients with adverse skin conditions (such as rash, active inflammation, etc.) in the device placement area, or those requiring emergency surgical intervention in that area.
- Patients who need to undergo computed tomography (CT), X-ray, or magnetic resonance imaging (MRI) scans on the device placement area during the study period.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
China · 1 center
- Continuous glucose monitoring system — Changsha
Identifiers
NCT: NCT07108179 · SN-CGM-PO-002